Shoulder Impingement Syndrome — ClinicCompanion. Compared to the Use of a Goniometer
Citation(s)
Dutta T Evaluation of the Kinect™ sensor for 3-D kinematic measurement in the workplace. Appl Ergon. 2012 Jul;43(4):645-9. doi: 10.1016/j.apergo.2011.09.011. Epub 2011 Oct 20.
Khoshelham K, Elberink SO Accuracy and resolution of Kinect depth data for indoor mapping applications. Sensors (Basel). 2012;12(2):1437-54. doi: 10.3390/s120201437. Epub 2012 Feb 1.
MacDermid JC, Chesworth BM, Patterson S, Roth JH Intratester and intertester reliability of goniometric measurement of passive lateral shoulder rotation. J Hand Ther. 1999 Jul-Sep;12(3):187-92.
Mullaney MJ, McHugh MP, Johnson CP, Tyler TF Reliability of shoulder range of motion comparing a goniometer to a digital level. Physiother Theory Pract. 2010 Jul;26(5):327-33. doi: 10.3109/09593980903094230.
Riddle DL, Rothstein JM, Lamb RL Goniometric reliability in a clinical setting. Shoulder measurements. Phys Ther. 1987 May;67(5):668-73.
van de Pol RJ, van Trijffel E, Lucas C Inter-rater reliability for measurement of passive physiological range of motion of upper extremity joints is better if instruments are used: a systematic review. J Physiother. 2010;56(1):7-17. Review.
A Study of Effectiveness of clinicCompanion. Compared to the Use of a Goniometer for Range of Motion Measurement.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
